Assessing Breast Cancer Risk Perception in Hispanic, Black, and Black Hispanic Women

Overview

About this study

The purpose of this study is to understand how women of color from diverse racial and ethnic backgrounds conceptualize their current and lifetime risk for breast cancer (BC) and to identify which risk factors most resonate with perceptions of BC risk.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Self-identify as female.
  • All racially/ethnically diverse women from the Mayo Clinic FLA and Mayo Clinic AZ cancer center catchment area.
  • Between the ages of 18 and 50.
  • No medical history of breast cancer.
  • Reside in the MCF and MCA catchment area (see study population description above).

Exclusion Criteria: 

  • Unable to understand or comprehend English or Spanish.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 10/5/23. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Megan Allyse, Ph.D.

Open for enrollment

Contact information:

Jhenitza Raygoza M.P.H.

(480) 342-4360

Raygoza.Jhenitza@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Jessica Austin, Ph.D.

Open for enrollment

Contact information:

Jhenitza Raygoza M.P.H.

(480) 342-4360

Raygoza.Jhenitza@mayo.edu

More information

Publications

Publications are currently not available

Additional contact information

Cancer-related trials contact form

Phone: 855-776-0015 (toll-free)

International patient clinical studies questions